Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.53 (
sialidase
)
2,694
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently we reported the first known incidence of antibodies possessing catalytic
sialidase
activity (
sialidase
abzymes) in the serum of patients with multiple myeloma and systemic lupus erythematosus (SLE). These antibodies desialylate biomolecules, such as glycoproteins, gangliosides and red blood cells. Desialylation of dying cells was demonstrated to facilitate apoptotic cell clearance. In this study we assessed the possibility to facilitate dying cell clearance with the use of F(ab)2 fragments of
sialidase
abzymes. Two sources of
sialidase
abzymes were used: (i) those isolated from sera of patients with SLE after preliminary screening of a cohort of patients for
sialidase
activity; and (ii) by creating an induced
sialidase
abzyme through immunization of a rabbit with synthetic hapten consisting of a non-hydrolysable analogue of
sialidase
reaction conjugated with bovine
serum albumin
(BSA) or keyhole limpet haemocyanin (KLH). Antibodies were purified by ammonium sulphate precipitation, protein-G affinity chromatography and size exclusion-high performance liquid chromatography (HPLC-SEC). Effect of desialylation on efferocytosis was studied using human polymorphonuclear leucocytes (PMN), both viable and aged, as prey, and human monocyte-derived macrophages (MoMa). Treatment of apoptotic and viable prey with both disease-associated (purified from blood serum of SLE patients) and immunization-induced (obtained by immunization of rabbits)
sialidase
abzymes, its F(ab)2 fragment and bacterial neuraminidase (as positive control) have significantly enhanced the clearance of prey by macrophages. We conclude that
sialidase
abzyme can serve as a protective agent in autoimmune patients and that artificial abzymes may be of potential therapeutic value.
...
PMID:Desialylation of dying cells with catalytically active antibodies possessing sialidase activity facilitate their clearance by human macrophages. 2458 Jun 40
<< Previous
1
2